These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6690026)

  • 1. Cytogenetic studies in ovarian cancer.
    Whang-Peng J; Knutsen T; Douglass EC; Chu E; Ozols RF; Hogan WM; Young RC
    Cancer Genet Cytogenet; 1984 Jan; 11(1):91-106. PubMed ID: 6690026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome.
    Bullerdiek J; Bartnitzke S; Kahrs E; Schloot W
    Cytobios; 1985; 42(165):15-24. PubMed ID: 3858061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14.
    Wake N; Hreshchyshyn MM; Piver SM; Matsui S; Sandberg AA
    Cancer Res; 1980 Dec; 40(12):4512-8. PubMed ID: 7438085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of chromosome 6 in endometrial cancer.
    Tibiletti MG; Bernasconi B; Taborelli M; Furlan D; Fabbri A; Franchi M; Taramelli R; Trubia M; Capella C
    Br J Cancer; 1997; 75(12):1831-5. PubMed ID: 9192990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetics of a cell line derived from an ovarian papillary serous cystadenocarcinoma.
    Hill SM; Rodgers CS; Hultén MA; Wilson AP
    Cancer Genet Cytogenet; 1984 Aug; 12(4):321-7. PubMed ID: 6744227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic abnormalities in serous papillary adenocarcinoma of the ovary.
    Sahin I; Yilmaz Z; Sahin FI
    Eur J Gynaecol Oncol; 2004; 25(5):585-6. PubMed ID: 15493170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome aberrations in nine patients with ovarian cancer.
    Tanaka K; Boice CR; Testa JR
    Cancer Genet Cytogenet; 1989 Nov; 43(1):1-14. PubMed ID: 2790764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal analysis in malignant ovarian tumors.
    Sonwalker AA; Grover S
    Am J Obstet Gynecol; 1974 Apr; 118(7):961-5. PubMed ID: 4361960
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromosome study of three ovarian tumors.
    Jenkyn DJ; McCartney AJ
    Cancer Genet Cytogenet; 1987 Jun; 26(2):327-37. PubMed ID: 3471312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma.
    Thompson FH; Emerson J; Alberts D; Liu Y; Guan XY; Burgess A; Fox S; Taetle R; Weinstein R; Makar R
    Cancer Genet Cytogenet; 1994 Mar; 73(1):33-45. PubMed ID: 8174072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic study of solid ovarian tumors.
    Roberts CG; Tattersall MH
    Cancer Genet Cytogenet; 1990 Sep; 48(2):243-53. PubMed ID: 2397455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic findings in cell lines derived from four ovarian carcinomas.
    Smith A; Roberts C; van Haaften-Day C; den Dulk G; Russell P; Tattersall MH
    Cancer Genet Cytogenet; 1987 Feb; 24(2):231-42. PubMed ID: 3466675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
    el-Naggar AK; Pathak S
    Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms.
    Tibiletti MG; Bernasconi B; Furlan D; Bressan P; Cerutti R; Facco C; Franchi M; Riva C; Cinquetti R; Capella C; Taramelli R
    Clin Cancer Res; 2001 Nov; 7(11):3404-9. PubMed ID: 11705855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of clonal variants in a human ovarian carcinoma studied by chromosome banding analysis.
    Trent JM; Thompson FH; Buick RN
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):153-61. PubMed ID: 3965120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL).
    Whang-Peng J; Bunn PA; Knutsen T; Matthews MJ; Schechter G; Minna JD
    Cancer; 1982 Oct; 50(8):1539-53. PubMed ID: 6981450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome abnormalities in primary endometrioid ovarian carcinoma.
    Yonescu R; Currie JL; Hedrick L; Campbell J; Griffin CA
    Cancer Genet Cytogenet; 1996 Apr; 87(2):167-71. PubMed ID: 8625265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors.
    Tharapel SA; Qumsiyeh MB; Photopulos G
    Cancer Genet Cytogenet; 1991 Aug; 55(1):89-96. PubMed ID: 1913613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.